Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial
- 1 January 1997
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 349 (9045) , 75-78
- https://doi.org/10.1016/s0140-6736(96)03031-0
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Contemporary reperfusion therapy for cardiogenic shock: The GUSTO-I trial experienceJournal of the American College of Cardiology, 1995
- Variations in Patient Management and Outcomes for Acute Myocardial Infarction in the United States and Other CountriesPublished by American Medical Association (AMA) ,1995
- Current Spectrum of Cardiogenic Shock and Effect of Early Revascularization on MortalityCirculation, 1995
- Use of Medical Resources and Quality of Life after Acute Myocardial Infarction in Canada and the United StatesNew England Journal of Medicine, 1994
- Outcome of Thrombolytic Therapy in Relation to Hospital Size and Invasive Cardiac ServicesArchives of internal medicine (1960), 1994
- Differences in the Treatment of Myocardial Infarction in the United States and CanadaArchives of internal medicine (1960), 1994
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- A Comparison of Management Patterns after Acute Myocardial Infarction in Canada and the United StatesNew England Journal of Medicine, 1993
- Comparative case fatality analysis of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial: Variation by country beyond predictive profileJournal of the American College of Cardiology, 1993
- Cardiogenic Shock after Acute Myocardial InfarctionNew England Journal of Medicine, 1991